AAS
JNJ icon

Asset Allocation Strategies’s Johnson & Johnson JNJ Stock Holding History

Asset Allocation Strategies’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Sell
1,041
-99
-9% -$23.1K 0.04% 163
2026
Q1 		$279K Buy
1,140
+152
+15% +$35.4K 0.05% 147
2025
Q4 		$204K Buy
+988
New +$195K 0.04% 160

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Asset Allocation Strategies's JNJ Position: Q2 2026 in Review

Asset Allocation Strategies reduced its Johnson & Johnson (JNJ) stake by 8.7% in Q2 2026, selling an estimated $23.1K and leaving 1,041 shares worth $264K. The position accounts for 0.04% of the portfolio, ranked #163.

Asset Allocation Strategies first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $279K in Q1 2026. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Asset Allocation Strategies held 1,041 shares of Johnson & Johnson worth $264K as of Q2 2026.
  • Asset Allocation Strategies sold 99 Johnson & Johnson shares in Q2 2026, an estimated $23.1K.
  • Johnson & Johnson made up 0.04% of Asset Allocation Strategies's portfolio in Q2 2026, its #163 holding.
  • Asset Allocation Strategies first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Asset Allocation Strategies's Johnson & Johnson position peaked at $279K in Q1 2026.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Asset Allocation Strategies's 13F filing for Q2 2026, filed 17 Aug 2026.